Andreas Halvorsen's position in Edgewise Therapeutics is currently worth $60.5 Million. That's 0.23% of their equity portfolio (69th largest holding). The investor owns 3.56% of the outstanding Edgewise Therapeutics stock. The first Edgewise Therapeutics trade was made in Q1 2021. Since then Andreas Halvorsen bought shares four more times and sold shares on two occasions. The investor's estimated purchase price is $69.2 Million, resulting in a loss of 13%.